180 related articles for article (PubMed ID: 32412824)
21. Immunoglobulin G subclass levels and antibody responses to the 2009 influenza A (H1N1) monovalent vaccine among human immunodeficiency virus (HIV)-infected and HIV-uninfected adults.
Crum-Cianflone NF; Collins G; Defang G; Iverson E; Eberly LE; Duplessis C; Maguire J; Ganesan A; Agan BK; Lalani T; Whitman T; Brandt C; Faix D; Blair PJ; Burgess T
Clin Exp Immunol; 2012 Apr; 168(1):135-41. PubMed ID: 22385248
[TBL] [Abstract][Full Text] [Related]
22. Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy.
Kroon FP; Rimmelzwaan GF; Roos MT; Osterhaus AD; Hamann D; Miedema F; van Dissel JT
AIDS; 1998 Dec; 12(17):F217-23. PubMed ID: 9863863
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients.
Ambati A; Einarsdottir S; Magalhaes I; Poiret T; Bodenstein R; LeBlanc K; Brune M; Maeurer M; Ljungman P
Transpl Infect Dis; 2015 Jun; 17(3):371-9. PubMed ID: 25817044
[TBL] [Abstract][Full Text] [Related]
24. HIV infection Worsens Age-Associated Defects in Antibody Responses to Influenza Vaccine.
George VK; Pallikkuth S; Parmigiani A; Alcaide M; Fischl M; Arheart KL; Pahwa S
J Infect Dis; 2015 Jun; 211(12):1959-68. PubMed ID: 25556252
[TBL] [Abstract][Full Text] [Related]
25. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
[TBL] [Abstract][Full Text] [Related]
26. Low expression of activation marker CD69 and chemokine receptors CCR5 and CXCR3 on memory T cells after 2009 H1N1 influenza A antigen stimulation in vitro following H1N1 vaccination of HIV-infected individuals.
Chawansuntati K; Chotirosniramit N; Sugandhavesa P; Aurpibul L; Thetket S; Kosashunhanan N; Supindham T; Kaewthip O; Sroysuwan P; Sirisanthana T; Suparatpinyo K; Wipasa J
Hum Vaccin Immunother; 2015; 11(9):2253-65. PubMed ID: 26091502
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapy.
Tanzi E; Esposito S; Bojanin J; Amendola A; Trabattoni D; Pariani E; Pinzani R; Zanetti A; Principi N
J Med Virol; 2006 Apr; 78(4):440-5. PubMed ID: 16482542
[TBL] [Abstract][Full Text] [Related]
28. Seroprotection of HIV-infected subjects after influenza A(H1N1) vaccination is directly associated with baseline frequency of naive T cells.
Ramirez LA; Daniel A; Frank I; Tebas P; Boyer JD
J Infect Dis; 2014 Aug; 210(4):646-50. PubMed ID: 24610877
[TBL] [Abstract][Full Text] [Related]
29. Antibody Responses with Fc-Mediated Functions after Vaccination of HIV-Infected Subjects with Trivalent Influenza Vaccine.
Kristensen AB; Lay WN; Ana-Sosa-Batiz F; Vanderven HA; Madhavi V; Laurie KL; Carolan L; Wines BD; Hogarth M; Wheatley AK; Kent SJ
J Virol; 2016 Jun; 90(12):5724-5734. PubMed ID: 27053553
[TBL] [Abstract][Full Text] [Related]
30. Decreased ratio of influenza-specific IgG versus IgM in response to influenza vaccination in antiretroviral-treated HIV-infected African Americans compared to Caucasians, and its direct correlation with the percentages of peripheral Tfh cells.
Ma P; Luo Z; Qian J; Yan Z; Zhang L; Martin L; Wang Z; Xia H; Yu F; Jiang W
Vaccine; 2020 Feb; 38(8):1998-2004. PubMed ID: 31948820
[TBL] [Abstract][Full Text] [Related]
31. Immunogenicity of a 2009 pandemic influenza virus A H1N1 vaccine, administered simultaneously with the seasonal influenza vaccine, in children receiving chemotherapy.
Ottóffy G; Horváth P; Muth L; Sólyom A; Garami M; Kovács G; Nyári T; Molnár D; Pauler G; Jankovics I
Pediatr Blood Cancer; 2014 Jun; 61(6):1013-6. PubMed ID: 24395342
[TBL] [Abstract][Full Text] [Related]
32. Kinetics of the antibody response to seasonal influenza vaccination among the elderly.
Kositanont U; Assantachai P; Wasi C; Puthavathana P; Praditsuwan R
Viral Immunol; 2012 Dec; 25(6):471-6. PubMed ID: 23061793
[TBL] [Abstract][Full Text] [Related]
33. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults.
Sarsenbayeva G; Volgin Y; Kassenov M; Issagulov T; Bogdanov N; Sansyzbay A; Stukova M; Buzitskaya Z; Кulmagambetov I; Davlyatshin T; Khairullin B
Hum Vaccin Immunother; 2018 Mar; 14(3):609-614. PubMed ID: 29112488
[TBL] [Abstract][Full Text] [Related]
35. Host immune response to A(H1N1)pdm09 vaccination and infection: a one-year prospective study on six cohorts of subjects.
Liu W; Ma MJ; Tang F; He C; Zhang XA; Jiang LF; Xin DS; Hu CY; Looman C; Cao WC
Vaccine; 2012 Jul; 30(32):4785-9. PubMed ID: 22633868
[TBL] [Abstract][Full Text] [Related]
36. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.
Schmidt T; Dirks J; Enders M; Gärtner BC; Uhlmann-Schiffler H; Sester U; Sester M
Eur J Immunol; 2012 Jul; 42(7):1755-66. PubMed ID: 22585549
[TBL] [Abstract][Full Text] [Related]
37. Impact of aging and HIV infection on serologic response to seasonal influenza vaccination.
Pallikkuth S; De Armas LR; Pahwa R; Rinaldi S; George VK; Sanchez CM; Pan L; Dickinson G; Rodriguez A; Fischl M; Alcaide M; Pahwa S
AIDS; 2018 Jun; 32(9):1085-1094. PubMed ID: 29424779
[TBL] [Abstract][Full Text] [Related]
38. Dysfunctional peripheral T follicular helper cells dominate in people with impaired influenza vaccine responses: Results from the FLORAH study.
Pallikkuth S; de Armas LR; Rinaldi S; George VK; Pan L; Arheart KL; Pahwa R; Pahwa S
PLoS Biol; 2019 May; 17(5):e3000257. PubMed ID: 31100059
[TBL] [Abstract][Full Text] [Related]
39. Artificial Intelligence Applied to
Cotugno N; Santilli V; Pascucci GR; Manno EC; De Armas L; Pallikkuth S; Deodati A; Amodio D; Zangari P; Zicari S; Ruggiero A; Fortin M; Bromley C; Pahwa R; Rossi P; Pahwa S; Palma P
Front Immunol; 2020; 11():559590. PubMed ID: 33123133
[TBL] [Abstract][Full Text] [Related]
40. High seroprotection rates and geometric mean titre increases after repeated annual influenza vaccinations in a cohort of HIV-infected adults in Austria.
Kitchen M; Leierer G; Kistner O; Wodal W; Gisinger M; Zangerle R; Sarcletti M
Vaccine; 2022 Jun; 40(29):3948-3953. PubMed ID: 35606234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
